This inventor holds 1 USPTO granted patent. Top assignee: University of Rhode Island. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations of Robert Deering
Introduction
Robert Deering is an accomplished inventor based in Wakefield, Rhode Island. He has made significant contributions to the field of biomedical research, particularly in the development of compositions that enhance the efficacy of antibiotics. His innovative work focuses on utilizing cranberry-derived compounds to combat bacterial persistence.
Latest Patents
Robert Deering holds a patent for "Cranberry-derived compositions for potentiating antibiotic efficacy against bacterial persistence." This invention provides compositions derived from cranberry, including xyloglucan, pectic oligosaccharides, and iridoid terpene glycosides. These compositions can be used in conjunction with antibiotics to synergistically kill bacterial persister cells and inhibit bacterial quiescent phenotypes. This advancement aims to improve treatment outcomes in recurrent and other infections.
Career Highlights
Deering is affiliated with the University of Rhode Island, where he conducts research and develops innovative solutions to pressing health issues. His work has garnered attention for its potential to enhance antibiotic treatments, addressing a critical challenge in modern medicine.
Collaborations
Some of his notable coworkers include David C. Rowley and Jiadong Sun. Their collaborative efforts contribute to the advancement of research in the field of antibiotic efficacy and bacterial resistance.
Conclusion
Robert Deering's innovative contributions to antibiotic efficacy through cranberry-derived compositions highlight the importance of interdisciplinary research in addressing health challenges. His work exemplifies the potential of natural compounds in enhancing medical treatments.